Close Menu

NEW YORK – In vitro diagnostics company Todos Medical announced Thursday it has entered into an exclusive option agreement to acquire Provista Diagnostics.

Financial and other terms of the deal were not disclosed.

Provista is currently developing and commercializing its Videssa blood test for breast cancer, which has been clinically validated for early detection.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.